MD Anderson research shows modern chemotherapies are tied to a small but significant increased risk of secondary MDS and AML in older breast cancer patients. These findings may help oncologists understand their patients’ risks and better inform discussions with them.
An overview of arsenic trioxide-involved combined treatment algorithms for leukemia: basic concepts and clinical implications
Blood Cancers Overview - History, Advancements and Challenges
Which Workplace Chemicals Raise the Risk for Leukemia?
Children with ALL Can Skip Brain Radiation - NCI
How to protect liver during chemotherapy
Leukemia: Causes and Risk Factors
Cancer Research News American Cancer Society
Frontiers Long-Term Effects of Pediatric Acute Lymphoblastic Leukemia Chemotherapy: Can Recent Findings Inform Old Strategies?
Preventing Cancer: Risk Factors AACR Cancer Progress Report 2020
Acute Lymphoblastic Leukemia Market Share and Size to 2031
Chemotherapy at home: 9 things to know
Leukemia in adults: Common types, symptoms, and treatment
Why Does The Risk Of Getting Cancer Increase As We Get Older - OHC